Smile

Based in Japan, Smile operates pharmacies that provide comprehensive pharmaceutical services, focusing on prescription fulfillment and medication management for diverse clientele within the Tokushima region and beyond. Smile was founded in 1998 and is headquartered in Tokushima-shi, Japan. The company specializes in pharmacy services, particularly in prescription fulfillment. In January 2026, Awagin Capital acquired Smile, although financial terms were not disclosed.

The acquisition supports Smile's business foundation and workforce development, facilitating long-term growth. Smile Pharmacy Group offers a comprehensive range of pharmaceutical services centered on prescription fulfillment, catering to a wide array of medical specialties. The company's core offerings include the acceptance and processing of prescriptions from nearly all medical departments, alongside an online prescription submission system available across its numerous locations. Through its extensive network of pharmacies throughout Tokushima Prefecture, Smile Pharmacy Group effectively serves local residents and healthcare providers, ensuring that the community's healthcare needs are met.

The revenue model of Smile Pharmacy Group is primarily built on transaction-based sales of pharmaceutical products and services directly to consumers. Clients visit the pharmacies to fill prescriptions, which drives revenue generation. The company engages in partnerships with healthcare providers to streamline the prescription process, enhancing convenience for end-users. Transactions occur on a per-prescription basis, where customers are billed for medications dispensed and any additional services offered.

This transactional framework positions Smile Pharmacy Group as a key player in the pharmaceutical retail sector. In January 2026, Smile will utilize the acquisition by Awagin Capital to reinforce its business foundation and broaden its store network. This will support long-term growth and sustainability. The company plans to develop its workforce, which will enhance its service delivery capabilities.

Specific future products or services have not been detailed, but the focus will likely remain on expanding within existing markets in Japan.